Launches Empamore For Diabetes, Heart Failure, And Kidney Disease
17/03/2025 13:19
Morepen Laboratories Ltd MORL.NS: MOREPEN LABORATORIES LTD - LAUNCHES EMPAMORE FOR DIABETES, HEART FAILURE, AND KIDNEY DISEASE Source text: ID:nBSE6jPcgn Further company coverage: MORL.NS
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall